Procter & Gamble (NYSE:PG) Price Target Raised to $190.00

Procter & Gamble (NYSE:PG) had its price objective lifted by UBS Group from $172.00 to $190.00 in a report published on Friday, MarketBeat.com reports. UBS Group currently has a buy rating on the stock.

PG has been the topic of several other reports. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, September 21st. JPMorgan Chase & Co. raised their price objective on Procter & Gamble from $162.00 to $180.00 and gave the company an “overweight” rating in a report on Friday. Royal Bank Of Canada set a $169.00 target price on Procter & Gamble in a research report on Friday. Evercore upgraded Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target for the company in a research note on Tuesday, October 6th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and set a $149.00 price target on shares of Procter & Gamble in a research report on Monday, August 24th. Fifteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $168.90.

Procter & Gamble Trading Up 0.1%

PG opened at $161.21 on Friday. The firm’s fifty day moving average is $148.41 and its two-hundred day moving average is $147.12. The firm has a market cap of $373.64 billion, a PE ratio of 24.28, a price-to-earnings-growth ratio of 4.00 and a beta of 0.39. Procter & Gamble has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.53 and a current ratio of 0.72.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. The firm had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The business’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.99 earnings per share. Equities research analysts anticipate that Procter & Gamble will post 6.98 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be paid a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s payout ratio is currently 65.51%.

Insider Buying and Selling

In related news, insider Susan Whaley sold 2,369 shares of the company’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $344,310.46. Following the sale, the insider directly owned 30,730 shares in the company, valued at $4,466,298.20. This represents a 7.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Andre Schulten sold 3,914 shares of the stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $568,860.76. Following the sale, the chief financial officer directly owned 65,618 shares of the company’s stock, valued at $9,536,920.12. This represents a 5.63% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 15,135 shares of company stock valued at $2,189,970 over the last 90 days. 0.23% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Procter & Gamble

Institutional investors have recently modified their holdings of the company. Mowery & Schoenfeld Wealth Management LLC acquired a new position in Procter & Gamble in the second quarter valued at $26,000. Montgomery Financial Services LLC bought a new stake in Procter & Gamble during the second quarter valued at $28,000. Paladin Partners LLC bought a new stake in Procter & Gamble during the second quarter valued at $29,000. Evergreen Advisors LLC acquired a new stake in Procter & Gamble during the 1st quarter worth about $37,000. Finally, Toews Corp ADV acquired a new stake in Procter & Gamble during the 2nd quarter worth about $37,000. 65.77% of the stock is owned by institutional investors.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
• Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
• Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
• Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.